s6y
Company name or ticker
Search
SNYDERMAN RALPH
3
ARGOS THERAPEUTICS INC: Initial statement of beneficial ownership of securities
Filed
Tuesday, December 13, 2016
Period
Dec 9, 2016
Accession number
0001178031-16-000001
Documents
PRIMARY DOCUMENT
3
POWER OF ATTORNEY
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header